Akari Therapeutics to Present at the Jefferies Complement Symposium
Apr 03, 2017 11:01 am UTC| Business
NEW YORK and LONDON, April 03, 2017 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will present at the...
Akari Therapeutics to Present at the Jefferies Complement Symposium
Apr 03, 2017 11:01 am UTC| Business
NEW YORK and LONDON, April 03, 2017 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will present at the...
Apr 03, 2017 11:01 am UTC| Business
NEW YORK, April 03, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Apr 03, 2017 11:01 am UTC| Business
NEW YORK, April 03, 2017 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
Apr 03, 2017 11:01 am UTC| Business
NEW YORK, April 03, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced that it has regained...
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
Apr 03, 2017 11:01 am UTC| Business
NEW YORK, April 03, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced that it has regained...
Apr 03, 2017 11:00 am UTC| Business
GERMANTOWN, Md. and BOSTON, April 03, 2017 -- Intrexon Corporation (NYSE:XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, ZIOPHARM Oncology...
US–India Trade Talks Race Toward USD 500 Billion Goal